Actively Recruiting
A Multi-centric Trial to Evaluate the Efficacy of Electronic-Based Psychosocial Interventions on Future Suicide Risk Among Adolescent Suicide Attempters
Led by University of Pittsburgh · Updated on 2026-04-07
168
Participants Needed
2
Research Sites
13 weeks
Total Duration
On this page
Sponsors
U
University of Pittsburgh
Lead Sponsor
F
Fogarty International Center of the National Institute of Health
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to evaluate the effectiveness of an electronic psycho-social intervention designed to improve coping and problem-solving skills to reduce suicidal behavior among adolescents who have attempted suicide. The study targets adolescents aged 12 to 18 years and seeks to bridge gaps in access to care for those at risk of suicide. It is a randomized controlled trial comparing two approaches to support this vulnerable group. Participants will be randomly assigned to one of two groups: one group receives an electronic psycho-social intervention via video-based telepsychiatry sessions focused on brief interventions and coping skills, delivered in five sessions on days 10, 30, 45, 60, and 90 after initial assessment. The other group receives treatment as usual, consisting of five regular telephonic reminder calls on the same schedule, providing emotional support and reminders for follow-up. Both groups are followed over a one-year period. Participants undergo screening for eligibility, provide consent, and complete baseline assessments using several standardized questionnaires. Follow-up assessments occur at 1, 3, 6, and 12 months post-intervention, measuring outcomes such as persistent suicidal thoughts, suicide attempts, depression, and coping ability. The study includes careful monitoring and data collection to ensure proper conduct and evaluation of the interventions. The total duration of involvement for each participant is up to one year after the baseline intervention.
CONDITIONS
Brief Title
Efficacy of EBPSI on Future Suicide Risk Among Adolescent Suicide Attempters
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adolescents aged 12 to 18 years
- Have attempted suicide within the last 30 days and presented to the study site
- Includes participants of all genders
- Medically stable with normal blood pressure, breathing rates, no fever, and full orientation to time, place, and person
You will not qualify if you...
- Current or lifetime diagnosis of psychosis as per ICD-10 criteria
- History of mental retardation or neurological conditions causing cognitive impairment
- Diagnosis of substance dependence (excluding tobacco) within the last six months
- Serious medical illness such as end-stage cancer, AIDS, or recent acute cardiovascular or cerebrovascular events within one month
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants complete baseline assessments including questionnaires and clinical scales after consent and eligibility confirmation.
1 baseline visit (in-person)
Duration - 90 days
Participants receive either video-based telepsychiatry sessions focused on brief intervention and coping skills, or telephonic supportive psychotherapy calls as usual care.
5 scheduled sessions on days 10, 30, 45, 60, and 90 after baseline intervention (video or phone)
Duration - 12 months
Participants complete follow-up assessments at 1, 3, 6, and 12 months after baseline intervention to monitor outcomes and intervention acceptability.
4 follow-up visits for assessments at 1, 3, 6, and 12 months
Trial Site Locations
Total: 2 locations
1
St John's Medical College and Hospital
Bengaluru, Karnataka, India, 560034
Actively Recruiting
2
Kalinga Institute of Medical Sciences (KIMS),
Bhubaneswar, Odisha, India, 751024
Actively Recruiting
Research Team
V
Vishwajit L Nimgaonkar, MD, PhD
T
Triptish Triptish, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here